BRIEF-Pliant Therapeutics Receives FDA Fast Track Designation For PLN-101095 In Combination With Pembrolizumab For The Treatment Of Ici-Refractory Solid Tumors

Reuters2026/08/18 12:31

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Crypto Zhong Liang: Market data shows repeated shakeouts, but the core BTC low-long strategy remains unchanged!

AiCoin•2026/09/12 13:05

Dogecoin Price Analysis: Bitwise’s BWOW ETF Shutdown Puts DOGE’s $0.08 Support at Risk

CoinEdition•2026/09/12 12:27

Quantinuum management attends Piper Sandler Growth Frontiers conference

Reuters•2026/09/12 12:02

The Expected Golden Cross in Bitcoin Has Happened—So What’s the Outcome?

BitcoinSistemi•2026/09/12 11:57